OCTOBIDPublic Tender GazetteAdvanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
synopsis monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- synopsis
- Solicitation number
- RFA-CA-27-002
- Posted
- June 3, 2026
- Response deadline
- November 10, 2026
- Location
- US
- Estimated value
- $300,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications w…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.